Extended Data Fig. 8
a. Representative growth inhibition curves, IC50s, and AUC values n = 7, mean ± SD) corresponding to Fig. 6a of indicated AML cells treated with increasing doses of venetoclax in presence of AZ2 or ARM165 after three days of seeding. b-c. Growth inhibition curves, IC50s, and AUC values (n = 3 biological replicates composed of seven technical replicates, mean ± SD), of OCI-AML2 cells treated with increasing doses of cytarabine, daunorubicin, or venetoclax in combination with 500 nM ARM165. P-values calculated using one-way ANOVA and reported on the figure panel.
